CN102416153B - Medicament for treating rheumatic arthritis - Google Patents
Medicament for treating rheumatic arthritis Download PDFInfo
- Publication number
- CN102416153B CN102416153B CN 201110402597 CN201110402597A CN102416153B CN 102416153 B CN102416153 B CN 102416153B CN 201110402597 CN201110402597 CN 201110402597 CN 201110402597 A CN201110402597 A CN 201110402597A CN 102416153 B CN102416153 B CN 102416153B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- rheumatic arthritis
- radix
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating rheumatic arthritis. The medicament is prepared from the following bulk pharmaceuticals in parts by weight: 100 parts of dried ginger, 70 parts of prepared common monkshood daughter root, 50 parts of crude kusnezoff monkshood root, 50 parts of wild ginger, 50 parts of Chinese angelica, 80 parts of orientvine, 170 parts of notopterygium root, 70 parts of white mustard seed, 30 parts of divaricate saposhnikovia root, 75 parts of rhubarb and 50 parts of seed of nuxvomica poison nut. The medicament for treating the rheumatic arthritis disclosed by the invention has the advantages of quick response, effectiveness, difficulty in reoccurring, low cost and easiness for producing, and is suitable for the requirements of most rheumatic arthritis patients.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament that is used for the treatment of rheumatic arthritis.
Background technology
Rheumatism is at the chronic pain that medically is articulations digitorum manus and surrounding soft tissue's unknown cause thereof.Rheumatism refers to that then different the but common ground of a large class cause of disease for involving joint and surrounding soft tissue, comprises the disease of flesh, ligament, synovial bursa, fascia.Arthropathy has pain outward still with swelling and moving obstacle, is outbreak and alleviates the chronic course of disease alternately.Because patient's blood circulation is obstructed, cause muscle or organize needed nutrition to carry by blood circulation, cause patient's muscle to lack nutrition and accelerated ageing becomes stiff, serious meeting causes patient's muscle and blood vessel atrophy, some patients were and can occur that disable in the joint and viscera function is depleted.
Typical case's performance of rheumatic arthritis is slight or the moderate heating, migratory polyarthritis, the joint of getting involved mostly is the large joint such as knee joint ankle, shoulder, elbow wrist, commonly be transferred to another joint by a joint; the pathological changes part presents redness, scorching hot, severe pain part patient also has several joints to fall ill simultaneously; atypical patient only has arthralgia and without other inflammation performances, acute inflammation generally disappears in 2-4 week and do not stay sequela, but normal arthropathy shows effect repeatedly.If active rheumatism affects heart and myocarditis then can occur even leave over valve disorder.
In order to solve these miseries, people have carried out a large amount of research, but therapeutic effect is not desirable especially.
Summary of the invention
The purpose of this invention is to provide a kind of medicament that is used for the treatment of rheumatic arthritis.
The present invention also aims to provide a kind of medicament for the treatment of rheumatic arthritis, it is to be made by the following raw material medicaments in part by weight meter: Rhizoma Zingiberis 100, Radix Aconiti Lateralis Preparata 70, Radix Aconiti Kusnezoffii 50, Herba Asari 50, Radix Angelicae Sinensis 50, Caulis Sinomenii 80, Rhizoma Et Radix Notopterygii 170, Semen Sinapis Albae 70, Radix Saposhnikoviae 30, Radix Et Rhizoma Rhei 75 and Semen Strychni 50.
Preferably, described medicament is tablet, dispersible tablet, unguentum or capsule.
In real process, as required, the doctor can also be used other drug, perhaps even with acupuncture comes auxiliary treatment.
The inventor is medical old and well-known family, and medicament of the present invention is the crystallization of the inventor's many years of experience, and pharmaceutical treatment rheumatic arthritis of the present invention is effective fast, be difficult for recurrence, prescription is simple, and is with low cost, produce easily, be fit to most of rheumatic arthritis patient's needs.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 unguentum of the present invention
Get Rhizoma Zingiberis 100 grams, Radix Aconiti Lateralis Preparata 70 grams, Radix Aconiti Kusnezoffii 50 grams, Herba Asari 50 grams, Radix Angelicae Sinensis 50 grams, Caulis Sinomenii 80 grams, Rhizoma Et Radix Notopterygii 170 grams, Semen Sinapis Albae 70 grams, Radix Saposhnikoviae 30 grams, Radix Et Rhizoma Rhei 75 grams and Semen Strychni 50 grams, micronization is pulverized, and crosses 100 mesh sieves, mix homogeneously.Add liquid paraffin 80 grams, lanoline 40 grams and vaseline 750 grams in the powder of above-mentioned mix homogeneously, be stirred to and be even paste and get final product.
Experimental example
Clinical observation material:
1, accept patient's totally 300 examples for medical treatment, male's 200 examples wherein, women's 100 examples, the men and women it. than being 2: 1, age 6-10 year 5 examples, 20-30 year 50 examples, 31 years old-40 years old 55 examples, 190 examples more than 40 years old.Light-duty phases 30 example wherein, medium-sized 250 examples, heavy 20 examples.
2, diagnostic criteria:
Rheumatic arthritis is a kind of chronic rheumatoid joint property disease, the clinical three types that is divided into:
1. light-duty phase: petit mal, sick type is lighter, and their early stage unexpected joint trick was ached 2-3 days, occurred without lump.
2. medium-sized phase: random wind rains and will shift to an earlier date outbreak in 2-3 days whenever, and lump, pain appear in locality trick arthralgia, even numb 2-3 days of trick meeting, and the fiber crops pain is felt in trick, inconvenience, does not have power.
3. heavy phase: grand mal, there is not random wind to rain no matter have, patient understands the whole body joint and tingles unbearably, trick splenalgia even modification, motion is inconvenient, and whole body is uncomfortable, and patient can't take care of oneself.
3, Therapeutic Method
Use the unguentum of preparation among the embodiment 1.Every day 2 times, each once applies 10 grams at every turn in the affected part sooner or later, treats continuously for two weeks.
4, efficacy assessment standard
Produce effects: behind drug treatment, health takes a turn for the better, and the intermission prolongs, and observing in two and half does not have the recidivist.
Take a turn for the better: physical condition takes a turn for the better, and the intermission prolongs relatively.
Invalid: as not reach improvement standard person.
5, efficacy result
Through treatment, 300 people reach the produce effects standard, obvious effective rate 100%.
Claims (2)
1. medicament for the treatment of rheumatic arthritis, it is to be made by the following raw material medicaments in part by weight meter: Rhizoma Zingiberis 100, Radix Aconiti Lateralis Preparata 70, Radix Aconiti Kusnezoffii 50, Herba Asari 50, Radix Angelicae Sinensis 50, Caulis Sinomenii 80, Rhizoma Et Radix Notopterygii 170, Semen Sinapis Albae 70, Radix Saposhnikoviae 30, Radix Et Rhizoma Rhei 75 and Semen Strychni 50.
2. the medicament for the treatment of rheumatic arthritis according to claim 1 is characterized in that, described medicament is tablet, unguentum or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110402597 CN102416153B (en) | 2011-12-07 | 2011-12-07 | Medicament for treating rheumatic arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110402597 CN102416153B (en) | 2011-12-07 | 2011-12-07 | Medicament for treating rheumatic arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102416153A CN102416153A (en) | 2012-04-18 |
| CN102416153B true CN102416153B (en) | 2013-04-03 |
Family
ID=45940954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110402597 Expired - Fee Related CN102416153B (en) | 2011-12-07 | 2011-12-07 | Medicament for treating rheumatic arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102416153B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083637B (en) * | 2013-01-28 | 2013-12-25 | 马秀连 | Pharmaceutical composition for treating rheumatism |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095730A (en) * | 2007-07-19 | 2008-01-02 | 钱贵生 | Medicine for treating rheumatism atrophic arthritis |
-
2011
- 2011-12-07 CN CN 201110402597 patent/CN102416153B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102416153A (en) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101234188B (en) | Pharmaceutical composition for treating pain and preparation thereof | |
| CN101491572A (en) | Medicine for treating calculus and preparation method thereof | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN103393895B (en) | Bone-setting traditional Chinese medicine decoction and preparation method thereof | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN102416153B (en) | Medicament for treating rheumatic arthritis | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN103784541A (en) | Traditional Chinese medicine for treating pains on neck, shoulders, waist and legs | |
| CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
| CN103394061B (en) | Externally-applied traditional Chinese medicine powder for treating hernia | |
| CN102755424B (en) | A kind of oral medicinal liquor for the treatment of sciatica | |
| CN102319330B (en) | Traditional Chinese medicine cataplasma for treating hyperosteogeny and preparation method thereof | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN101249236B (en) | Chinese and western medicine combined preparations for curing epileptic | |
| CN101361868B (en) | Traditional Chinese medicine combination for treating rheumatism | |
| CN103933143A (en) | External-use traditional Chinese medicine for treating rheumatoid arthritis | |
| CN108310163A (en) | A kind of dispelling wind-evil and wetness-evil blood-activating Chinese medicine preparation and preparation method thereof | |
| CN102552742B (en) | Medicine for treating scapulohumeral periarthritis and rheumatism | |
| CN102258589B (en) | Deer blood medicinal wine for treating rheumatoid arthritis | |
| CN1861119B (en) | Traditional Chinese medicine for treating rheumatosis and its preparation method | |
| CN101732408B (en) | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof | |
| CN105250641A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN103768575B (en) | A kind of clinical care is used for the treatment of the preparation method of the Chinese medicine composition of osteopathia | |
| CN109364174A (en) | A kind of drug and preparation method thereof for treating rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20151207 |
|
| EXPY | Termination of patent right or utility model |